Read
Reuters Photojournalism
Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography. See more | Photo caption
Egypt's Mursi protests
Egyptian President Mohamed Mursi clings to office as protesters demand that he resign. Slideshow
Obama in Africa
President Obama is seeking to build a new economic partnership with Africa at the end of a tour of the fast-growing continent. Slideshow
Sponsored Links
Onyx to test cancer drug for wider use
(Reuters) - Onyx Pharmaceuticals Inc said it was planning to test its approved blood cancer drug Kyprolis in patients with newly diagnosed multiple myeloma.
The drug, known generically as carfilzomib, was initially approved to treat multiple myeloma, a type of blood cancer, in patients who did not respond to other medicines.
Sales of Kyprolis, which was launched last July, has crossed $62 million in 2012, Onyx Chief Executive Officer Anthony Coles said at a J.P. Morgan Healthcare Conference on Monday.
Onyx also said its partner Pfizer Inc will start a late-stage study of a breast cancer drug this year. Onyx will receive a royalty on sales if the drug is approved.
Shares of the San Francisco, California-based company were trading up 5 cents at $81.52 on Monday afternoon on the Nasdaq.
(Reporting By Pallavi Ail in Bangalore; Editing by Roshni Menon)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints




Follow Reuters